Zenas BioPharma Slams Investor's Revamped Fraud Claim
Zenas BioPharma has asked a Massachusetts federal judge to toss a putative investor class action targeting pre-initial public offering statements about the company's spending, saying it didn't hide that it had...To view the full article, register now.
Already a subscriber? Click here to view full article